HOME >> MEDICINE >> NEWS
ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)

Sophia Antipolis, France, 22 March 2005: The European Society of Cardiology (ESC) releases the first European Guidelines on Percutaneous Coronary Interventions (PCI), pre-published and accessible on the ESC Web Site(1). According to these Guidelines, PCI can now be regarded as the first option for a larger group of patients with acute coronary syndromes (ACS) than before. Recent technical and pharmacological improvements have developed PCI into a procedure that can be safely and effectively applied to patients with various types of coronary lesions and patients with and without myocardial infarction.

The ESC Guidelines on PCI represent the consensus of a Task Force of European experts(1), chaired by Professor Sigmund Silber of the Gemeinschaftspraxis Hospital, Munich, Germany, Fellow of the ESC. Professor Silber outlines the highlights of the Guidelines and summarises the recommendations, whilst outlining the rationale behind their timing and their relevance to the European healthcare arena.

ESC PCI Guidelines highlights

One of the most pertinent points of the ESC guidelines is that thrombolysis for myocardial infarction can be administered within the first 3 hours after onset of chest pain, if no catheter lab is accessible, preferably within 90 minutes. Thrombolysis, however, should not be regarded as the final treatment stage: even if successful, thrombolysis should still be followed by invasive diagnosis and treatment, if applicable. A patient may feel fine after thrombolysis, but there is significant evidence that he/she should still undergo cardiac catheterisation, optimally within 24 hours after successful thrombolysis.

Due to the differences in the infrastructure between the USA and Europe, the ESC Guidelines differ from those of the USA (issued by the American College of Cardiology and American Heart Association)(2) when addressing issues of time and distance to catheter laboratories. The European Guidelines
'"/>

Contact: Camilla Dormer
cdormer@escardio.org
33-492-94-8627
European Society of Cardiology
22-Mar-2005


Page: 1 2 3 4 5

Related medicine news :

1. Guide to releases
2. USP releases first-ever case study book to advance medication error prevention
3. USP releases fourth annual report on medication errors in U.S. hospitals
4. Mayo Clinic proceedings releases West Nile virus manuscript early to aid clinicians, public
5. NIAID releases 20th anniversary edition of Jordan Report on vaccine research
6. Childrens Hospital Boston releases results at the American Academy of Pediatrics Annual Meeting
7. The lancet specialty journals press releases
8. Journal of Rehabilitation R&D releases latest issue
9. Medical press releases may exaggerate results and fail to include study limitations
10. ACP-ASIM releases plan to eliminate uninsured by 2009
11. HFES releases new multiperspective book on team activities

Post Your Comments:
(Date:5/21/2013)... Woodland, CA (PRWEB) May 21, 2013 ... Johnson executive Brian Perkins as its Chairman of the ... held by Perkins at Johnson & Johnson during his ... the Johnson & Johnson Executive Committee, Worldwide Chairman of ... Products. At J&J, Perkins helped to develop and build ...
(Date:5/21/2013)... Overweight and obese patients are significantly more likely ... care doctors, a practice that disrupts continuity of ... new Johns Hopkins research suggests. , The practice ... a result of negative experiences with the health ... office staff, unsolicited weight loss advice by providers, ...
(Date:5/21/2013)... ESHRE (European Society of Human Reproduction & Embryology) is ... over 9000 experts are expected this year, presenting a ... which is of great public interest. Reports from proceedings ... of news and features. , This year,s event will ... from 7th to 10th July. , The scientific programme ...
(Date:5/21/2013)... As the summer season kicks off, ... camp or beginning practice for summer or fall sports. ... or sporting activities can begin. , To help parents during ... youth sports or camp physicals at just $29. ... review a child’s medical history, perform a physical exam and ...
(Date:5/21/2013)... obstructive pulmonary disease (COPD) patients experience a significant ... levels are nearly on par with the kind ... arthritis patients, according to the study, which is ... Society annual meeting in Philadelphia. "Several studies ... among COPD patients, and pain has also been ...
Breaking Medicine News(10 mins):Health News:Former Johnson & Johnson Executive Brian Perkins Named Chairman of Puroast® Coffee 2Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:MedSpring Offers Affordable Youth Physicals for $29 2Health News:Pain a Common Problem for People With COPD 2
(Date:5/21/2013)... , May 21, 2013 Sanofi (EURONEXT: ... REGN) today announced that the New England Journal ... study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe ... the alpha subunit of the interleukin 4 receptor (IL-4R ... drivers of Th2 (Type 2 helper T cell) immune ...
(Date:5/21/2013)... 21, 2013  BioRestorative Therapies, Inc. ("BRT" or the ... on developing stem cell based therapies for various personal ... its President and CEO, will be presenting at the ... be held on Thursday, May 30, 2013 at the ... in New York City.  Mr. Weinreb,s presentation will take ...
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , ... bidding procurement program for home medical equipment is ... North Carolina to lay off employees or ... quality of service and products received by Medicare beneficiaries, ... the defective and dangerous program, the Centers for ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
Cached News: